Article Information
History
- March 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ida Rask Moustsen-Helms1,*,
- Hanne-Dorthe Emborg1,
- Jens Nielsen1,
- Katrine Finderup Nielsen1,
- Tyra Grove Krause1,
- Kåre Mølbak1,
- Karina Lauenborg Møller2,
- Ann-Sofie Nicole Berthelsen2 and
- Palle Valentiner-Branth1
- 1Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark
- 2Infectious Disease Preparedness, Data Integration and Analysis, Statens Serum Institut, Copenhagen, Denmark
- ↵*Corresponding Author:
Ida Rask Moustsen-Helms, PhD, Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen, Denmark. Tel: + 45 32 68 36 92, Email:irmh{at}ssi.dk
Posted March 09, 2021.
Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers – a Danish cohort study
